ExitValue.ai
Industry Guide9 min readApril 2026

How to Value a Pediatric Therapy Practice in 2026

Pediatric therapy practices — the ones combining physical therapy, occupational therapy, and speech-language pathology under one roof — have become one of the more sought-after acquisition targets in healthcare services. The combination of recurring demand (children don't outgrow developmental delays on a buyer's timeline), multi-disciplinary revenue streams, and a fragmented ownership base has attracted PE-backed platforms that barely looked at this space five years ago.

But valuing a pediatric therapy practice requires understanding nuances that don't exist in adult rehab or general outpatient therapy. The payer mix is different. The referral dynamics are different. And the staffing economics — particularly for speech-language pathologists — can make or break the valuation story. Let me walk through what actually matters.

The Multiple Range and What Shapes It

Pediatric therapy practices trade at 4-8x EBITDA, with the range driven by scale, service mix, contract quality, and how dependent the practice is on the founding clinician. Single-location practices with 3-5 therapists and heavy owner involvement sell at the lower end. Multi-site practices with 15+ therapists, diversified payer contracts, and management infrastructure command the upper end.

The spread is wide because this space straddles two buyer universes. At 4-5x, you're selling to another clinician or a small group expanding locally, and they're using SDE-based valuation because they plan to treat patients themselves. At 6-8x, you're selling to a PE-backed platform builder who sees your practice as a node in a regional or national network — and they're paying for the infrastructure, not your clinical skills.

Early Intervention Contracts: Predictable Revenue, Complex Billing

State-funded early intervention (EI) programs — Part C of IDEA — are a significant revenue source for many pediatric therapy practices. Children birth to age 3 with developmental delays qualify for state-funded therapy, and practices that hold EI provider contracts get a steady flow of referrals that doesn't depend on physician relationships or marketing.

Buyers view EI contracts as a double-edged sword. The referral volume is predictable and the demand is essentially recession-proof. But EI reimbursement rates are set by state agencies, they vary wildly by state ($50-120 per session), and they can change with legislative budget cycles. A practice where EI represents 50%+ of revenue faces real rate risk that buyers will model conservatively.

The strongest valuation profile has EI as 20-35% of revenue — large enough to demonstrate the referral pipeline, but balanced by commercial insurance and private-pay revenue that carries higher margins. If EI dominates your revenue, you're at the mercy of state budget decisions, and buyers know it.

Autism Services: The Growth Premium

Practices that have built meaningful autism spectrum disorder (ASD) service lines — particularly Applied Behavior Analysis (ABA) combined with speech and OT — command valuation premiums that can push above the standard range. ABA-focused companies trade at 8-14x EBITDA in the current market. A pediatric therapy practice with an established ABA component captures some of that premium.

The key word is "established." Buyers want to see credentialed BCBAs on staff, insurance panel participation for ABA specifically, demonstrated outcomes documentation, and a waitlist that proves demand exceeds current capacity. A practice that offers "autism services" but doesn't have board-certified behavior analysts or structured ABA programming won't get the premium.

The insurance landscape for ABA has expanded dramatically — most states now mandate coverage, and major commercial payers have built ABA networks. If your practice is in-network with BCBS, UnitedHealthcare, and Aetna for ABA services, that panel participation has real value to a buyer building a multi-state platform.

School District Contracts: Stable but Capped

Many pediatric therapy practices supplement clinic-based revenue with school district contracts, providing PT, OT, and speech services to students with IEPs (Individualized Education Programs). These contracts are attractive because they're predictable — school districts must provide mandated services and they renew annually — but they carry characteristics that buyers evaluate carefully.

School contracts typically pay lower rates than commercial insurance (often 30-50% less per session). They're seasonal, with revenue dropping during summer months. And they often require therapists to travel to multiple school sites, reducing the number of billable sessions per day compared to a clinic setting.

The sweet spot for valuation is school contracts representing 15-25% of total revenue. That demonstrates diversification and community relationships without over-indexing on a lower-margin channel. Practices where school contracts exceed 40% of revenue will see buyers discount their EBITDA margins against a scenario where those contracts are lost or renegotiated at lower rates.

Therapist Retention: The Make-or-Break Factor

I cannot overstate how central therapist retention is to pediatric therapy practice valuation. Pediatric speech-language pathologists are among the hardest healthcare professionals to recruit nationally. OTs and PTs with pediatric specialization aren't far behind. If your practice has a stable clinical team, that stability is one of your most valuable assets.

Buyers will ask for therapist tenure data, turnover rates over the past three years, compensation benchmarking against market rates, and whether therapists are employees or independent contractors. Practices with average therapist tenure above 3 years and annual turnover below 15% get meaningfully better multiples than those churning through clinicians.

The contractor-versus-employee question is a genuine risk factor. If your therapists are classified as 1099 contractors, buyers will evaluate misclassification risk and may require you to indemnify them against reclassification liabilities. The IRS and state labor departments have been aggressive on this issue in healthcare, and a buyer's legal team will scrutinize it.

Credentialing depth also matters. Practices where multiple therapists hold specialty certifications — Sensory Integration (SIPT), PROMPT for speech, NDT for physical therapy — demonstrate a clinical sophistication that supports higher rates and differentiates from competitors. A buyer looking at a platform acquisition wants to see clinical depth, not just headcount.

What Kills Pediatric Therapy Practice Value

Founder dependency. If the founding clinician handles 30%+ of the patient caseload and all the referral relationships run through them personally, buyers see a practice that may not survive the transition. The two-year earnout structures common in these deals exist precisely because buyers need the founder to stay and gradually transfer those relationships.

Single-payer dependency. A practice where one insurance company or one state program represents more than 40% of revenue faces concentration risk. Payer contract renegotiations, rate cuts, or credentialing changes can crater revenue overnight.

Facility constraints. Pediatric therapy requires specialized space — sensory gyms, suspended equipment, therapy swings, and private treatment rooms. If your lease is expiring, your space is maxed out with no room to add treatment rooms, or your facility doesn't meet ADA requirements, these are material issues that buyers price into their offers or use to renegotiate terms during diligence.

The Bottom Line

Pediatric therapy practices sit at the intersection of strong demographic demand, insurance mandate expansion (particularly for autism services), and a fragmented market that PE platforms are actively consolidating. If your practice has a balanced payer mix, a stable therapist team, some ABA or autism specialization, and management that doesn't depend entirely on the founder, you're well positioned in the 6-8x EBITDA range. The practices that sell for 4-5x are typically single-location, founder-dependent, and heavily reliant on a single revenue channel. The gap between those outcomes is worth planning for years in advance.

Want to see what your business is worth?

Institutional-quality estimates backed by 25,000+ real M&A transactions.

Get Your Valuation Estimate

Ready to See What Your Business Is Worth?

Start Your Valuation